Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Tandem Diabetes Care, Inc. (TNDM)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
43.12-1.15 (-2.60%)
At close: 04:00PM EST
43.50 +0.38 (+0.88%)
After hours: 07:11PM EST
Advertisement

Tandem Diabetes Care, Inc.

11075 Roselle Street
San Diego, CA 92121
United States
858 366 6900
https://www.tandemdiabetes.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees2,000

Key Executives

NameTitlePayExercisedYear Born
Mr. John F. SheridanPres, CEO & Director1.6M1.36M1955
Ms. Leigh A. VossellerExec. VP, CFO & Treasurer764.64k5.57M1973
Mr. David B. Berger Esq.Exec. VP & COO765.11k5.62M1970
Ms. Susan M. MorrisonExec. VP & Chief Admin. Officer764.35k6.16M1979
Mr. Brian B. HansenExec. VP & Chief Commercial Officer781.22k2.26M1968
Ms. Elizabeth Anne GasserExec. VP & Chief Strategy Officer764.64k1.21M1976
Mr. Rick A. CarpenterChief Technical OfficerN/AN/A1963
Ms. Shannon M. HansenSr. VP, Gen. Counsel, Chief Compliance Officer & Corp. Sec.N/AN/A1966
Mr. Ross SylviaVP of MarketingN/AN/AN/A
Mr. Tom FoxSr. VP of HR & Organizational Devel.N/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Corporate Governance

Tandem Diabetes Care, Inc.’s ISS Governance QualityScore as of December 1, 2022 is 5. The pillar scores are Audit: 9; Board: 5; Shareholder Rights: 5; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement